Genome and epigenome wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk (2021)
Attributed to:
UK Dementias Platform
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.06.07.21258457
Publication URI: http://dx.doi.org/10.1101/2021.06.07.21258457
Type: Preprint